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A new approach to induce directed mutations i  genes ofstudy through simple cotransfection of E. coli cells by the mix- 
ture of primer and template was developed. This method is based on the use of synthetic phosphotriester analogues of 
oligonucleotides as site-specific mutagenic primers. The achieved yield of mutant clones was 2-3~. 
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1. INTRODUCTION 
It has been known for a long while that natural 
polynucleotides have a mutagenic influence on the 
cell genome 011. For example, while treating cells 
with transforming DNA carrying a mutant gene, 
chromosomal DNA becomes mutant for the same 
gene 121. The method of ‘marker rescue’ used in the 
mapping of viral genes is also based on the 
mutagenic effect of DNA fragments [3]. It has been 
shown previously that polynucleotides of several 
hundred nucleotides and more in length have a 
noticeable mutagenic potential [3,4]. Mutagenesis 
has a low efficiency (not greater than 0.1 B/o) if short 
synthetic oligodeoxy-ribonucleotides in vivo are 
used [4,5]. To increase the yield of mutants and 
mutagenesis pecificity it has been necessary to 
work out special methods of enzymatic synthesis of 
oligonucleotides up to a full-length mutant copy of 
the starting DNA in vitro [4,6]. One of the reasons 
for low efficiency of oligonucleotide-directed 
mutagenesis in vivo is the sensitivity of short syn- 
thetic oligodeoxyribonucleotides to cell nucleases 
[4]. For the first time the present paper shows the 
possibility of high-effective induction of in vivo 
directed mutations in the genes through cotransfec- 
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tion of bacterial cells by the mixture of DNA and 
phosphotriester analogues of oligonucleotides [7] 
which serve as mutagenic primers, but which are 
proofed against destruction by nucleases. 
2. MATERIALS AND METHODS 
Single-stranded DNA of M13pmB phage [El, E. co/i strain 
JM103 [9], were used. Oligonucleotides, their synthesis and 
properties have been described previously [7] in detail. 
Oligonucleotides were phosphorylated for mutagenesis as 
described in [6]. Mutagenesis has been carried out in the follow- 
ing way: 20 pmol of oligonucleotides (5’-phosphorylated or 
without 5 ‘-terminal phosphate group) were added to 1 pmol of 
the M13mpB phage DNA in 10~1 of the solution containing 0.02 
M Tris-HCl (pH 7.5), 0.05 M NaCl, 0.01 M MgClz, 1 mM 
dithiothreitol. The mixture was kept at 20-23°C for 15-45 min. 
An aliquot of the mixture was used for transforming competent 
cells of E. co/i JM103. Transformation conditions and prepara- 
tion of single-stranded phage DNA for structural analysis have 
been described elsewhere [lo]. Mutants DNAs were sequenced 
by the dideoxychain-termination method [ll]. A 13-mer [12] 
was used as primer for DNA sequence analyses. 
3. RESULTS AND DISCUSSION 
We have previously shown that phosphotriester 
analogues were more effective mutagens when 
compared to phosphodiester oligonucleotides in 
oligonucleotide-directed in vitro mutagenesis ex- 
periments [7]. Phosphotriester links protect the 
mismatched area from the 5’-3’ and 3’-5’ ex- 
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Fig. 1. The structures of the mutagenic oligonucleotides and the sequence of the 1acZ’ gene region coding for the amino-terminus of the 
ru-peptide of,&galactosidase. Codons of the 1acZ’ gene are marked with figures. R, substituents at phosphate groups; Et, ethyl residue. 
onuclease activities of DNA polymerases [7] and 
probably from the repair enzymes of a cell. It was 
interesting for us to study the possibilities of the 
use of phosphotriester analogues of oligo- 
nucleotides for in vivo mutation induction. 
The mutagenic activity of phosphotriester 
analogues has been tested in template DNA of 
M13mpB phage [8]. Fig.1 demonstrates the struc- 
ture of the N-terminal site of the 1acZ’ gene 
(coding for a-peptide of fl-galactosidase) in 
M13mpB along with the structure of mutagenic 
oligonucleotides: 20-mer (20), its monoethyl 
(20-Et) and diethyl (20-Etz) esters; 17-mer (17), its 
diethyl (17-Etz- 1 and 17-Etz-2), triethyl (17-Ets) 
and tetraethyl (17-Et4) esters [7]. Oligonucleotides 
induce the deletion of the first or second nucleotide 
of the seventh codon of the Z’ gene, resulting in the 
Ml 3mpl AT deletion mutant of a different 
phenotype (Lac-) [8]. Complexes of oligo 
nucleotides with M13mpB phage DNA were used 
for transforming competent cells of E. coli JM103. 
A relative number of the mutant colonies served as 
a measure of efficiency of the mutagenesis nduced 
with oligonucleotides [13]. The results of the 
analysis are summarized in table 1 which demon- 
strates that the best mutagenic properties in vivo 
are displayed by stereoisomers of the diethyl ester 
of 17-Etz-2 and those of the triethyl ester of 17-Et3 
of the similar structure. As the mutagenic activities 
110 
of these analogues are almost identical in vitro [7] 
and in vivo tests, we conclude that the main proper- 
ty defining the efficiency of mutagenesis is the 
presence of ethylated phosphate groups distant 
from the molecule ends by 3 nucleotides. The yield 
Table 1 
The efficiency of ohgonucleotide-directed mutagenesis in vivo 
Oligonucleotide” The yield of mutants (O/O)~ induced by 
5 ’ -phosphorylated Non-phosphorylated 
oligonucleotides oligonucleotides 
20 
20-Et 
20-Et2 
17 
17-Etz-1 
17-Etz-2(l) 
17-Etz-2(2) 
17-Ets(l) 
17-Etr(2) 
17-Etn(3) 
17-Et4 
0.3 It 0.1 0.1 * 0.1 
0.5 * 0.1 0.8 f 0.1 
0.7 + 0.1 1.0 * 0.2 
0.2 * 0.1 _ 
0.1 * 0.1 - 
1.4 * 0.2 
2.5 + 0.5 
_ 
0.7 * 0.2 
0.8 ? 0.1 _ 
1.9 * 0.4 _ 
2.0 * 0.3 - 
not found _ 
a The structure is depicted in fig. 1. The number of the fraction 
in isolating stereoisomers by reversed-phase chromatography is 
given in parentheses [7] 
b Arithmetic mean and standard error according to the results of 
3-4 individual experiments: 5-8 inoculations of E. coli JM103 
cells separately transfected and characterized by different times 
of production were carried out in every test. Spontaneous 
background of Lac- mutants is <O. 1% 
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Fig.2. The dependency of the mutant yield upon the primer:template molar ratios in forming the 5’p-17-Etz-2(2):M13mpB DNA com- 
plex. The diagram shows the results of 5-6 individual tests. 
of mutants achieved 2-3% using these analogues 
which corresponds to an average value obtained in 
the majority of experiments on oligonucleotide- 
directed mutagenesis. Fig.2 demonstrates that a 
lo-13-fold excess of primer in reference to the 
template DNA is sufficient for effective 
mutagenesis in the conditions suggested. 
With the 5 ’ -phosphorylated analogue 17-Etz- 
2(2) we have obtained mutants by adding the 
oligonucleotide and M13mpB phage DNA to E. 
coli JM103 competent cells without preforming the 
DNA: primer complex in vitro. The yield of 
mutants is 1.2 f 0.3% (data of 5 individual tests). 
To prove specificity of mutagenesis we have 
selected mutant phage clones in each test and deter- 
mined the primary structure of their DNA in the 
linkage site of oligonucleotides by the method of 
Sanger [l 11. The majority of tests have shown the 
mutation determined by the structure of 
oligonucleotides (deletion C). Only the 17-Etz-1 
analogue resulted in the mutants containing the 
unplanned deletion of 262 nucleotides in length in- 
cluding the IacI gene end, regulatory region and a 
part of the structural region of the IacZ’ gene. The 
accurate structure of the DNA of the unplanned 
mutants and the description of the possible 
mechanism of their formation will be published 
later. 
Thus we have proposed a new solution to the 
problem of site-localized mutagenesis. It is based 
on one of the methods of synthetic organic 
chemistry and presupposes the incorporation of 
protecting groups into the oligonucleotide- 
mutagene in order to provide stability against 
destructive agents such as cell nucleases. The pre- 
sent paper shows that the use of synthetic 
analogues of oligonucleotides provides a new op- 
portunity for carrying out mutagenesis with genetic 
material of a vital cell. 
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